Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
7057 | THBS1 | thrombospondin 1 | |
7099 | TLR4 | toll like receptor 4 | |
7124 | TNF | tumor necrosis factor | |
7157 | TP53 | tumor protein p53 | |
9370 | ADIPOQ | adiponectin, C1Q and collagen domain containing | |
10133 | OPTN | optineurin | |
134430 | WDR36 | WD repeat domain 36 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
18127 | Nos3 | nitric oxide synthase 3, endothelial cell | |
18294 | Ogg1 | 8-oxoguanine DNA-glycosylase 1 | |
18979 | Pon1 | paraoxonase 1 | |
20656 | Sod2 | superoxide dismutase 2, mitochondrial | |
21825 | Thbs1 | thrombospondin 1 | |
21898 | Tlr4 | toll-like receptor 4 | |
21926 | Tnf | tumor necrosis factor | |
22059 | Trp53 | transformation related protein 53 | |
60596 | Gucy1a1 | guanylate cyclase 1, soluble, alpha 1 | |
83995 | Mmp1a | matrix metallopeptidase 1a (interstitial collagenase) |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24225 | Bdnf | brain-derived neurotrophic factor | |
24600 | Nos3 | nitric oxide synthase 3 | |
24787 | Sod2 | superoxide dismutase 2 | |
24835 | Tnf | tumor necrosis factor | |
24842 | Tp53 | tumor protein p53 | |
25149 | Esr2 | estrogen receptor 2 | |
25473 | Lamb2 | laminin subunit beta 2 | |
29260 | Tlr4 | toll-like receptor 4 | |
79558 | Acvr1 | activin A receptor type 1 | |
81523 | Myoc | myocilin |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
171999 | poml-2 | Arylesterase | |
174044 | sma-6 | Serine/threonine-protein kinase receptor sma-6 | |
176829 | daf-1 | Cell surface receptor daf-1 | |
177292 | lam-1 | Laminin subunit beta-1 | |
178748 | zmp-3 | Matrix metalloproteinase-C | |
182256 | R193.2 | VWFA domain-containing protein | |
187297 | poml-1 | PON (paraoxonase) and MEC-6 Like |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024